Lisinopril alters contribution of nitric oxide and KCa channels to vasodilatation in small mesenteric arteries of spontaneously hypertensive rats

Physiological Research

Volumn 64, Issue 1, 2015, Pages 39-49

  Albarwani, S ^a   Al Siyabi, S ^a   Al Husseini, I ^a   Al Ismail, A ^a   Al Lawati, I ^a   Al Bahrani, I ^a   Tanira, M O ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

ACE inhibition; Endothelium; KCa channels; Lisinopril; Nitric oxide; Small mesenteric arteries

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ACTIVATED POTASSIUM CHANNEL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; KCNMA1 PROTEIN, RAT; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNIT; LISINOPRIL; NITRIC OXIDE; NOS3 PROTEIN, RAT; POTASSIUM CHANNEL BLOCKING AGENT; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; VASODILATOR AGENT;

ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; HYPERTENSION; MALE; MESENTERIC ARTERY; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION; WISTAR KYOTO RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; LISINOPRIL; MALE; MESENTERIC ARTERIES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS, INBRED SHR; RATS, INBRED WKY; SIGNAL TRANSDUCTION; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; VASODILATION; VASODILATOR AGENTS;

EID: 84924915515     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ca channel downregulation in rat coronary arteries. Exp Physiol 95: 746-755, 2010.
2. ALBARWANI S, AL-SIYABI S, TANIRA MO: Lisinopril indifferently improves heart rate variability during day and night periods in spontaneously hypertensive rats. Physiol Res 62: 237-234, 2013.
3. BONDARENKO A, PANASIUK O, STEPANENKO L, GOSWAMI N, SAGACH V: Reduced hyperpolarization of endothelial cells following high dietary Na+: effects of enalapril and tempol. Clin Exp Pharmacol Physiol 39: 608-613, 2012.
4. BRäHLER S, KAISTHA A, SCHMIDT VJ, WöLFLE SE, BUSCH C, KAISTHA BP, KACIK M, HASENAU AL, GRGIC I, SI H, BOND CT, ADELMAN JP, WULFF H, DE WIT C, HOYER J, KöHLER R: Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension. Circulation 119: 2323-2332, 2009.
5. CRANE GJ, GALLAGHER N, DORA KA, GARLAND CJ: Small- and intermediate-conductance calcium-activated K+ channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery. J Physiol 15: 183-189, 2003.
6. DAL-ROS S, BRONNER C, SCHOTT C, KANE MO, CHATAIGNEAU M, SCHINI-KERTH VB, CHATAIGNEAU T: Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery. J Pharmacol Exp Ther 328: 478-486, 2009.
7. DAMKJAER M, NIELSEN G, BODENDIEK S, STAEHR M, GRAMSBERGEN JB, DE WIT C, JENSEN BL, SIMONSEN U, BIE P, WULFF H, KöHLER R: Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs. Br J Pharmacol 165: 223-234, 2012.
8. DEJA MA, GOLBA KS, WIDENKA K, MROZEK R, BIERNAT J, KOLOWCA M, MALINOWSKI M, WOS S: Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline-mediated endotheliumdependent relaxation in internal thoracic artery of hypertensive patients. Int J Cardiol 102: 455-460, 2005.
9. EDWARDS G, DORA KA, GARDENER MJ, GARLAND CJ, WESTON AH: K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998.
10. EDWARDS G, WESTON AH: Potassium and potassium clouds in endothelium-dependent hyperpolarizations. Pharmacol Res 49: 535-541, 2004.
11. ELLIS A, GOTO K, CHASTON DJ, BRACKENBURY TD, MEANEY KR, FALCK JR, WOJCIKIEWICZ RJ, HILL CE: Enalapril treatment alters the contribution of epoxyeicosatrienoic acids but not gap junctions to endothelium-derived hyperpolarizing factor activity in mesenteric arteries of spontaneously hypertensive rats. J Pharmacol Exp Ther 330: 413-422, 2009.
12. FéLéTOU M, VANHOUTTE PM: Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 26: 1215-1225, 2006.
13. FELETOU M, VANHOUTTE PM: EDHF: an update. Clin Sci (Lond) 117: 139-155, 2009.
14. FUJII K, TOMINAGA M, OHMORI S, KOBAYASHI K, KOGA T, TAKATA Y, FUJISHIMA M: Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res 70: 660-669, 1992.
15. GILES TD, SANDER GE, NOSSAMAN BD, KADOWITZ PJ: Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins. J Clin Hypertens (Greenwich) 14: 198-205, 2012.
16. GOTO K, FUJII K, ONAKA U, ABE I, FUJISHIMA M: Renin-angiotensin system blockade improves endothelial dysfunction in hypertension. Hypertension 36: 575-580, 2000.
17. GOTO K, FUJII K, KANSUI Y, IIDA M: Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors. Clin Exp Pharmacol Physiol 31: 650-655, 2004.
18. GOTO K, KANSUI Y, ONIKI H, OHTSUBO T, MATSUMURA K, KITAZONO T: Upregulation of endotheliumderived hyperpolarizing factor compensates for the loss of nitric oxide in mesenteric arteries of Dahl saltsensitive hypertensive rats. Hypertens Res 35: 849-854, 2012.
19. GRGIC I, KAISTHA BP, HOYER J, KöHLER R: Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses-relevance to cardiovascular pathologies and drug discovery. Br J Pharmacol 157: 509-526, 2009.
20. HALPERN W, MULVANY MJ, WARSHAW DM: Mechanical properties of smooth muscle cells in the walls of arterial resistance vessels. J Physiol 275: 85-101, 1978.
21. HILGERS RH, WEBB RC: Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension. Am J Physiol 292: H2275-H2284, 2007.
22. HILGERS RH, TODD J JR, WEBB RC: Regional heterogeneity in acetylcholine-induced relaxation in rat vascular bed: role of calcium-activated K+ channels. Am J Physiol 291: H216-H222, 2006.
23. HINTON JM, LANGTON PD: Inhibition of EDHF by two new combinations of K+-channel inhibitors in rat isolated mesenteric arteries. Br J Pharmacol 138: 1031-1035, 2003.
24. JEONG SY, HA TS, PARK CS, UHM DY, CHUNG S. Nitric oxide directly activates large conductance Ca2+- activated K+ channels (rSlo). Mol Cells 12: 97-102, 2001.
25. KUSAMA N, KAJIKURI J, YAMAMOTO T, WATANABE Y, SUZUKI Y, KATSUYA H, ITOH T: Reduced hyperpolarization in endothelial cells of rabbit aortic valve following chronic nitroglycerine administration. Br J Pharmacol 146: 487-497, 2005.
26. MAURICIO MD, ALDASORO M, ORTEGA J, VILA JM: Endothelial dysfunction in morbid obesity. Curr Pharm Des 19: 5718-5729, 2013.
27. MISTRY DK, GARLAND CJ: Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol 124: 1131-1140, 1998.
28. MORAWIETZ H, ROHRBACH S, RUECKSCHLOSS U, SCHELLENBERGER E, HAKIM K, ZERKOWSKI HR, KOJDA G, DARMER D, HOLTZ J: Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy. Eur J Clin Invest 36: 705-712, 2006.
29. NEUTEL JM: Effect of the renin-angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function. J Hum Hypertens 18: 599-606, 2004.
30. NILIUS B, DROOGMANS G: Ion channels and their functional role in vascular endothelium. Physiol Rev 81: 1415-1459, 2001.
31. RUBANYI GM: Endothelium-derived relaxing and contracting factors. J Cell Biochem 46: 27-36, 1991.
32. SANDOW SL, TARE M, COLEMAN HA, HILL CE, PARKINGTON HC: Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res 90: 1108-1113, 2002.
33. SANKARANARAYANAN A, RAMAN G, BUSCH C, SCHULTZ T, ZIMIN PI, HOYER J, KöHLER R, WULFF H: Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 75: 281-295, 2009.
34. SI H, HEYKEN WT, WöLFLE SE, TYSIAC M, SCHUBERT R, GRGIC I, VILIANOVICH L, GIEBING G, MAIER T, GROSS V, BADER M, DE WIT C, HOYER J, KöHLER R: Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 99: 537-544, 2006.
35. TAYLOR MS, BONEV AD, GROSS TP, ECKMAN DM, BRAYDEN JE, BOND CT, ADELMAN JP, NELSON MT: Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ Res 93: 124-131, 2003.
36. VILLAR IC, HOBBS AJ, AHLUWALIA A: Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor. J Endocrinol 197: 447-462, 2008.
37. WESTON AH, PORTER EL, HARNO E, EDWARDS G: Impairment of endothelial SK(Ca) channels and of downstream hyperpolarizing pathways in mesenteric arteries from spontaneously hypertensive rats. Br J Pharmacol 160: 836-843, 2010.
38. YANG Z, KAYE DM: Endothelial dysfunction and impaired L-arginine transport in hypertension and genetically predisposed normotensive subjects. Trends Cardiovasc Med 16: 118-124, 2006.
39. ZARITSKY JJ, ECKMAN DM, WELLMAN GC, NELSON MT, SCHWARZ TL: Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation. Circ Res 87: 160-166, 2000.
40. ZHANG H, SCHMEISSER A, GARLICHS CD, PLöTZE K, DAMME U, MüGGE A, DANIEL WG: Angiotensin IIinduced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res 44: 215-222, 1999.